Ledger.Open graph →
SEC Form D · filed July 17, 2020

Amunix Pharmaceuticals, Inc

Offering
$2.6M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MOUNTAIN VIEW, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Volker Schellenberger · Mountain View, CAExecDavid Hirsch · Mountain View, CADirectorRichard Heyman · Mountain View, CADirectorOtello Stampacchia · Mountain View, CADirectorAngie You · Mountain View, CAExec · DirectorJames Topper · Mountain View, CADirectorJames Brush · Mountain View, CADirectorMonika Garg · Rancho Santa Fe, CADirectorSerena Kim · Bethesda, MDDirectorAndrea Barthwell · Bethesda, MDExecBrandon Nielson · Salt Lake City, UTDirectorTodd J. Bazemore · Lexington, MADirectorDaniel Sundheim · New York, NYDirectorJohn Earl · Salt Lake City, UTExec · DirectorGuido Mallmann · Buenos Aires, C1DirectorBrent C. Adam · PORTLAND, ORExec · DirectorAnthony J. Bash · PORTLAND, ORDirectorCharles E. Harrell · PORTLAND, ORDirectorStuart Peterson · Austin, TXDirectorFrank Levinson · SAN MATEO, CADirectorJulia Davourie · SAN MATEO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗